Marc Bigaud - Concepedia

Author

Marc Bigaud

Novartis (Switzerland)

Also Known As

M Bigaud, M. BIGAUD, M. Bigaud, Marc Bigaud

Publications

717

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Centre National de la Recherche Scientifique University of Strathclyde Novartis Institutes for BioMedical Research

About

Marc Bigaud is an author at Novartis (Switzerland) specializing in medicine, physiology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	362
2	Health Sciences	2	2	133
3	Social Sciences	1	1	67
4	Anesthesia	1	1	51
5	Biochemistry	1	1	37

Marc Bigaud

Publications

679

Citations

H-Index

Page 1

	Year	Citations
Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation Frédéric Bornancin, Florian Renner, Ratiba Touil, The Journal of Immunology	2015	126
Alterations in myocardial contractility in conscious dogs with dilated cardiomyopathy Richard P. Shannon, Kazuo Komamura, Bruce S. Stambler, American Journal of Physiology-Heart and Circulatory Physiology Cardiac MuscleCardiomyopathyHeart FailureStructural Heart DiseaseCardiovascular Disease	1991	96
Discrimination between ET<sub>A</sub>‐ and ET<sub>B</sub>‐receptor‐mediated effects of endothelin‐1 and [Ala<sup>1,3,11,15</sup>]endothelin‐1 by BQ‐123 in the anaesthetized rat Marc Bigaud, John T. Pelton British Journal of Pharmacology	1992	93
Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation Nicolau Beckmann, Catherine Cannet, Madeleine Fringeli-Tanner, Magnetic Resonance in Medicine ImmunologyIron OxidePathologyImmunotherapyRat Model	2003	67
Enadotoxin-induced of vascular smooth contractions elicited by different mechanisms Marc Bigaud, Géraldine Julou‐Schaeffer, James R. Parratt, European Journal of Pharmacology MechanobiologyInflammationVascular Smooth ContractionsMolecular PhysiologyVascular Adaptation	1990	51
Pharmacology of the human metabolites of dolasetron, an antiemetic 5‐HT<sub>3</sub> receptor antagonist Marc Bigaud, Jack Elands, Philip R. Kastner, Drug Development Research Mdl 73Receptor AntagonistPharmacotherapyExperimental PharmacologyPre-clinical Pharmacology	1995	37
The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion Cherry L. Wainwright, J. R. Parratt, Marc Bigaud European Heart Journal	1989	37
The origin of cynomolgus monkey affects the outcome of kidney allografts under neoral immunosuppression K Menninger, Grazyna Wieczorek, Sabine C. Riesen, Transplantation Proceedings UrologyXenotransplantationTransplantationKidney TransplantKidney Allografts	2002	35
Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration Júlia Baguña Torres, Jay Roodselaar, Megan Sealey, Frontiers in Immunology	2022	32
Dissociation between endothelium-mediated increases in tissue cGMP levels and modulation of aortic contractile responses Marc Bigaud, Philippe Schoeffter, J.C. Stoclet, Naunyn-Schmiedeberg s Archives of Pharmacology InflammationTissue Cgmp LevelsMolecular PhysiologyAtherosclerosisVascular Pharmacology	1984	26

Page 1